EKF Diagnostics Holdings plc
EKF.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £50,194 | £52,611 | £66,635 | £81,836 |
| % Growth | -4.6% | -21% | -18.6% | – |
| Cost of Goods Sold | £28,714 | £28,752 | £42,597 | £42,470 |
| Gross Profit | £21,480 | £23,859 | £24,038 | £39,366 |
| % Margin | 42.8% | 45.3% | 36.1% | 48.1% |
| R&D Expenses | £1,345 | £1,823 | £1,518 | £1,378 |
| G&A Expenses | £18,078 | £19,680 | £23,177 | £17,709 |
| SG&A Expenses | £13,676 | £17,880 | £23,177 | £17,709 |
| Sales & Mktg Exp. | £0 | -£1,800 | £0 | £0 |
| Other Operating Expenses | £0 | £2,075 | £8,314 | -£1,468 |
| Operating Expenses | £15,021 | £21,778 | £33,009 | £17,619 |
| Operating Income | £6,459 | £2,081 | £7,564 | £21,747 |
| % Margin | 12.9% | 4% | 11.4% | 26.6% |
| Other Income/Exp. Net | -£196 | £50 | -£16,506 | -£312 |
| Pre-Tax Income | £6,263 | £2,131 | -£8,942 | £21,435 |
| Tax Expense | -£314 | -£600 | £634 | £5,277 |
| Net Income | £6,242 | £2,352 | -£10,101 | £15,851 |
| % Margin | 12.4% | 4.5% | -15.2% | 19.4% |
| EPS | 0.014 | 0.005 | -0.022 | 0.035 |
| % Growth | 165.4% | 123.5% | -163.7% | – |
| EPS Diluted | 0.014 | 0.005 | -0.022 | 0.034 |
| Weighted Avg Shares Out | 453,731 | 454,105 | 457,180 | 457,001 |
| Weighted Avg Shares Out Dil | 453,731 | 454,105 | 457,180 | 460,957 |
| Supplemental Information | – | – | – | – |
| Interest Income | £174 | £125 | £131 | £45 |
| Interest Expense | £171 | £75 | £102 | £68 |
| Depreciation & Amortization | £4,724 | £5,472 | £6,658 | £5,885 |
| EBITDA | £11,158 | £7,678 | -£2,182 | £27,388 |
| % Margin | 22.2% | 14.6% | -3.3% | 33.5% |